Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent during periods of severe air pollution, a survey has found out.

Nearly one-third of all nebuliser purchases were for children, reflecting the growing respiratory distress among younger age groups amid worsening air quality, the survey report noted.

The comprehensive survey was carried out by ‘Warrior Moms’ in collaboration with chemists in south, east, north and central Delhi last year, followed by a re-run with more pharmacists this year.

Chemists reported that sales of commonly prescribed asthma and respiratory medicines such as Asthalin, Levolin, Budecort and Seroflo rose significantly between November and January, when pollution levels typically peak.

In north Delhi alone, sales of some inhalers increased by about 40 per cent, while central and south Delhi outlets recorded a 50 to 60 per cent jump in demand for nebulisers.

Parents frequently complained of symptoms such as persistent cough, wheezing, breathlessness and chest tightness in children, with many chemists noting that these problems worsened during high-smog periods, especially in the early mornings and evenings, the survey said.

The report also highlighted supply challenges, with several pharmacies struggling to maintain stocks of high-demand items like Duolin Respules and Budecort nebulising solutions during peak pollution months.

Calling the findings a public health warning, the survey recommended advance stocking of respiratory aids, improved supply chain management and greater public awareness, particularly in schools, to help parents and children cope with pollution-related respiratory illnesses during Delhi’s winter season.

Related Posts

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

US President Donald Trump on Monday said nine pharmaceutical manufacturers, including Sun Pharma, have reached agreements with his administration to lower prescription drug prices for Americans in line with the…

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

Mumbai: The Maharashtra Nodal Cyber Police have registered an FIR against 22 foreign medical graduates for allegedly uploading fake and suspicious documents on Maharashtra Medical Council (MMC) portal to obtain…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

FUJIFILM India is zeroing in on Indian Gut with Advanced Therapeutic Endoscopy

FUJIFILM India is zeroing in on Indian Gut with Advanced Therapeutic Endoscopy

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government